The Hang Seng Index pulled back on Monday, reaching a low of H$26,628, down from this year’s high of H$27,165, after China published the latest GDP data and otherThe Hang Seng Index pulled back on Monday, reaching a low of H$26,628, down from this year’s high of H$27,165, after China published the latest GDP data and other

Hang Seng Index forecast after hitting a brick wall at H$27,165

3 min read

The Hang Seng Index pulled back on Monday, reaching a low of H$26,628, down from this year’s high of H$27,165, after China published the latest GDP data and other macro data. It remains much higher than last year’s low of H$19,220.

China’s GDP growth rate hits target, but slows in Q4

The Hang Seng Index and other Chinese indices remained on edge on Monday as investors digested the latest macro data, which showed that the economic growth hit the 5% target in 2025, even as it faced the challenge of the United States tariffs. This growth was higher than what many analysts, including World Bank, predicted.

Data published by the National Statistics Bureau (NBS) showed that the House Price Index (HPI) retreated by 2.7% in December after slowing by 2.4% in the previous month.. China’s housing sector has never recovered since the collapse of top companies like Evergrande.

More data showed that the retail sales growth eased to 0.9% in December from 1.3% in November, while industrial production rose by 5.2% during the month.

As a result, the economy expanded by 4.5%  in the fourth quarter, a big deceleration from the previous 4.8%.  This deceleration was mostly because of a drop in fixed asset investments as Beijing moved to clear hidden debt and reduce excess competition.

Another red flag for the country was that deflation continued for 11 quarters, while birth rates plunged to the lowest level in years.

Still, the country managed to hit its 5% annual target last year, and Beijing expects that the growth will accelerate later this year.

China’s growth was mostly driven by trade, which accelerated as more foreigners bought its products. While exports to the United States dropped in 2025, trends to other regions like Africa and South America surged during the year. Its trade surplus jumped to $1.2 trillion during the year.

Top gainers and laggards in the HSI Index 

The Hang Seng Index retreated after the latest Chinese data as concerns about geopolitics remained following Donald Trump’s decision to slap tariffs on some key NATO allies.

Most companies in the Hang Seng were in the red on Monday, with Wuxi Biologics falling by 5%. Innovent Biologics, Hansoh Pharmaceutical, Sino Biopharmaceutical, and WuXi AppTec were the top laggards as they plunged by over 4% on Monday.

The other top laggards in the Hang Seng Index were companies like Zhongsheng Group, New Oriental Education, Alibaba Group, Kuaishou Technology, and China Resources Land, which fell by over 2.6%.

On the other hand, Li Ning, China Mengniu Dairy, Baidu, and China Hongkiao were the best gainers.

Hang Seng Index technical analysis 

Hang Seng IndexHSI Index chart | Source: TradingView

The daily timeframe chart shows that the Hang Seng Index has hit a brick wall at H$27,165, its highest level in October and November last year, and in January this year. It has struggled to move above that level, a sign that bulls are hesitant to place bids.

The index has remained above the 50-day and 100-day Exponential Moving Averages (EMA). Therefore, the most likely Hang Seng Index forecast is neutral for now. 

More upside will be confirmed if it moves above the key resistance level at H$27,164. A move above that level will point to more gains, potentially to the strong pivot, reverse level of the Murrey Math Lines tool at H$27,343.

The post Hang Seng Index forecast after hitting a brick wall at H$27,165 appeared first on Invezz

Market Opportunity
Index Cooperative Logo
Index Cooperative Price(INDEX)
$0,2968
$0,2968$0,2968
-%3,06
USD
Index Cooperative (INDEX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
XRP Ledger Unlocks Permissioned Domains With 91% Validator Backing

XRP Ledger Unlocks Permissioned Domains With 91% Validator Backing

XRP Ledger activated XLS-80 after 91% validator approval, enabling permissioned domains for credential-gated use on the public XRPL. The XRP Ledger has activated
Share
LiveBitcoinNews2026/02/06 13:00
TrendX Taps Trusta AI to Develop Safer and Smarter Web3 Network

TrendX Taps Trusta AI to Develop Safer and Smarter Web3 Network

The purpose of collaboration is to advance the Web3 landscape by combining the decentralized infrastructure of TrendX with AI-led capabilities of Trusta AI.
Share
Blockchainreporter2025/09/18 01:07